Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Al B Benson

Showing results (201-210 of 350) with videos related to

Pageof 35
Sort By:
Liver Cancer|December 24, 2021
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation ProfilingRobin K Kelley, Nancy M Joseph, Halla S Nimeiri, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 11, 2016
Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and SurvivalSamdeep K Mouli, Ryan Hickey, Bartley Thornburg, et al.
Advances in Radiation Oncology|March 21, 2018
Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centersMarsha Reyngold, Joyce Niland, Anna Ter Veer, et al.
JCO Clinical Cancer Informatics|November 4, 2022
A Framework for Harmonization of Radiomics Data for Multicenter Studies and Clinical TrialsMoataz A S Soliman, Linda C Kelahan, Michael Magnetta, et al.
American Health & Drug Benefits|July 4, 2014
Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report, Gene Beed, Gary M Owens, et al.
The Oncologist|January 6, 2019
Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review StudyArvind Dasari, Emily K Bergsland, Al B Benson, et al.
Journal of Hepatology|January 17, 2012
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysisKhairuddin Memon, Laura Kulik, Robert J Lewandowski, et al.
Journal for Immunotherapy of Cancer|March 2, 2020
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancerMichael Overman, Milind Javle, Richard E Davis, et al.
The Oncologist|January 5, 2019
Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review StudyMatthew H Kulke, Al B Benson, Arvind Dasari, et al.
JMIR Research Protocols|January 22, 2019
TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical TrialNikhil Chauhan, Mary F Mulcahy, Riad Salem, et al.
Pageof 35

Showing results (201-210 of 350) with videos related to

Sort By:
Pageof 35
Liver Cancer|December 24, 2021
Phase II Trial of the Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma with Tumor Mutation ProfilingRobin K Kelley, Nancy M Joseph, Halla S Nimeiri, et al.
Journal of Vascular and Interventional Radiology : JVIR|April 11, 2016
Single- versus Triple-Drug Chemoembolization for Hepatocellular Carcinoma: Comparing Outcomes by Toxicity, Imaging Response, and SurvivalSamdeep K Mouli, Ryan Hickey, Bartley Thornburg, et al.
Advances in Radiation Oncology|March 21, 2018
Trends in intensity modulated radiation therapy use for locally advanced rectal cancer at National Comprehensive Cancer Network centersMarsha Reyngold, Joyce Niland, Anna Ter Veer, et al.
JCO Clinical Cancer Informatics|November 4, 2022
A Framework for Harmonization of Radiomics Data for Multicenter Studies and Clinical TrialsMoataz A S Soliman, Linda C Kelahan, Michael Magnetta, et al.
American Health & Drug Benefits|July 4, 2014
Defining Value in Cancer Care: AVBCC 2012 Steering Committee Report, Gene Beed, Gary M Owens, et al.
The Oncologist|January 6, 2019
Treatment Patterns and Clinical Outcomes in Advanced Lung Neuroendocrine Tumors in Real-World Settings: A Multicenter Retrospective Chart Review StudyArvind Dasari, Emily K Bergsland, Al B Benson, et al.
Journal of Hepatology|January 17, 2012
Alpha-fetoprotein response correlates with EASL response and survival in solitary hepatocellular carcinoma treated with transarterial therapies: a subgroup analysisKhairuddin Memon, Laura Kulik, Robert J Lewandowski, et al.
Journal for Immunotherapy of Cancer|March 2, 2020
Randomized phase II study of the Bruton tyrosine kinase inhibitor acalabrutinib, alone or with pembrolizumab in patients with advanced pancreatic cancerMichael Overman, Milind Javle, Richard E Davis, et al.
The Oncologist|January 5, 2019
Real-World Treatment Patterns and Clinical Outcomes in Advanced Gastrointestinal Neuroendocrine Tumors (GI NET): A Multicenter Retrospective Chart Review StudyMatthew H Kulke, Al B Benson, Arvind Dasari, et al.
JMIR Research Protocols|January 22, 2019
TheraSphere Yttrium-90 Glass Microspheres Combined With Chemotherapy Versus Chemotherapy Alone in Second-Line Treatment of Patients With Metastatic Colorectal Carcinoma of the Liver: Protocol for the EPOCH Phase 3 Randomized Clinical TrialNikhil Chauhan, Mary F Mulcahy, Riad Salem, et al.
Pageof 35